Arable Biotech Private Limited
About Arable Biotech Private Limited
Data last updated:
Arable Biotech Private Limited is a private limited company based in Delhi, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 03 May 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U01100DL2016PTC298998. Its GSTIN is 07AAOCA3914C1ZX (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Tsreenivasan and Sudha Sreenivasan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Shop No. 1 G/F Csc 2 Pocket B – 8 Kondli Gharoli Mayur Vihar Phase III, Delhi, India – 110096.
As per the financials filed for FY 2025, the company reported a revenue of ₹88,439. For the same year it recorded a net loss of ₹40,323 (net margin -45.6%) and EBITDA of -₹34,416 (EBITDA margin -38.9%). Revenue has declined at a compounded annual rate (CAGR) of 93% over three years and 16% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Arable Biotech Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressShop No. 1 G/F Csc 2 Pocket B – 8 Kondli Gharoli Mayur Vihar Phase III, Delhi, India – 110096
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
To see the full contact details of Arable Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Arable Biotech Private Limited
FY 2025 filings availableArable Biotech Private Limited reported revenue of ₹88,439 for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years. EBITDA rose 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹34,416 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹40,323 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -38.9% | ||||
| Net Profit Margin | -45.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Arable Biotech Private Limited, buy the company report.
Board of directors of Arable Biotech Private Limited
Arable Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Tsreenivasan | Director | 29 Sep 2018 | 8 Years 1 Months | Current |
| Sudha Sreenivasan | Director | 03 May 2016 | 10 Years 5 Months | Current |
Shareholding
The shareholding of Arable Biotech Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Arable Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Arable Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arable Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Arable Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAOCA3914C1ZX | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Arable Biotech Private Limited, buy the company report.
Recent activity
Arable Biotech Private Limited has 3 board changes on record since 2016: 2 appointments and 1 cessation. The latest: Neeru Mathur ceased to be Director on 01 Oct 2018.
Frequently asked questions
Arable Biotech is an active private limited company based in Delhi, India. The company works in chemical products, within the chemicals industry. It was incorporated on 03 May 2016 (10+ years old) and is registered under CIN U01100DL2016PTC298998.
Arable Biotech has 2 current directors:
- Tsreenivasan - Director
- Sudha Sreenivasan - Director
The latest financial statements of Arable Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Arable Biotech is 07AAOCA3914C1ZX, registered in Delhi.
The CIN (Corporate Identification Number) of Arable Biotech is U01100DL2016PTC298998. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arable Biotech was incorporated on 03 May 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
Neeru Mathur ceased to be Director on 01 Oct 2018. Tsreenivasan was appointed as Director on 29 Sep 2018. Sudha Sreenivasan was appointed as Director on 03 May 2016.
The registered office of Arable Biotech is at Shop No. 1 GF Csc 2 Pocket B – 8 Kondli Gharoli Mayur Vihar Phase III, Delhi, India – 110096.
Arable Biotech operates in the chemicals industry, in the chemical products segment.
The compliance status of Arable Biotech is compliant as of 12 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
